Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2020-03-24 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
关于使用部分暂时闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's use of temporarily idle funds to purchase financial products, detailing the progress, amounts, risk disclosures, and internal controls. It references a prior shareholders' meeting resolution approving the use of funds for cash management. The document is a formal public announcement of a financing activity related to cash management and investment products, not a full financial report or earnings release. It does not contain comprehensive financial statements or detailed management analysis. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities involving idle funds and investment products.
2020-03-24 Chinese
关于控股子公司吸附无细胞百白破（三组分）联合疫苗获得临床试验通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Changchun High-tech Industry Group Co., Ltd. regarding its controlling subsidiary receiving a clinical trial notification from the National Medical Products Administration for a vaccine. The content focuses on regulatory approval and clinical trial commencement, not financial results, management changes, or shareholder votes. The document is short (680 characters) and serves as an official announcement of a regulatory event related to product development. It does not contain financial data, management discussion, or meeting materials. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-03-12 Chinese
中信建投证券股份有限公司、中天国富证券有限公司关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之定向可转债发行情况之独立财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor's Verification Opinion" regarding the issuance of shares and convertible bonds by Changchun High-tech Industry (Group) Co., Ltd. It details the issuance of a directed convertible bond, including issuance approval, registration, asset transfer, and related financial and legal procedures. The document is a standalone verification opinion by independent financial advisors on the issuance of convertible bonds and related asset purchase and fundraising activities. It is not a full annual or interim report, nor is it a simple announcement or certification. It contains detailed information about the issuance, legal compliance, and financial advisory opinion, which fits the category of an Audit Report / Information (AR) as it is a standalone audit/verification report related to a specific transaction and issuance. The document length (over 14,000 characters) and detailed content confirm it is not a brief announcement or regulatory filing. Therefore, the appropriate classification is AR with high confidence. Q1 2020
2020-03-11 Chinese
关于发行股份及可转换债券购买资产并募集配套资金暨关联交易之定向可转债发行结果暨登记完成的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the issuance of shares and convertible bonds to purchase assets and raise supporting funds by Changchun High-tech Industry (Group) Co., Ltd. It includes specifics about the convertible bond issuance, registration completion, legal and financial advisor information, approval by regulatory authorities (China Securities Regulatory Commission), and detailed implementation status of the transaction. The document is not a full annual or interim report, nor is it a simple announcement of a report publication. It is a comprehensive disclosure about a capital raising and asset acquisition transaction involving convertible bonds and share issuance, including legal compliance, registration, and financial details. This fits the definition of a Capital/Financing Update (CAP).
2020-03-11 Chinese
北京市康达律师事务所关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之定向可转换公司债券发行情况及认购对象合规性的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the issuance of shares and convertible bonds by Changchun High-tech Industry (Group) Co., Ltd. It details the compliance, approvals, and implementation of a major asset restructuring involving issuance of shares and convertible bonds, including the legal compliance of the issuance and the qualifications of the subscribers. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to capital raising and issuance of convertible bonds. It is a detailed legal opinion on a capital/financing transaction, specifically on the issuance of convertible bonds and shares for asset purchase and fundraising. Therefore, the document fits best under the category Capital/Financing Update (CAP). The document length is substantial (over 11,000 characters) and contains detailed legal and transaction information, not just an announcement or certification, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2020-03-11 Chinese
关于控股子公司使用部分暂时闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Changchun High-tech Industry (Group) Co., Ltd. regarding the progress of its controlling subsidiary using temporarily idle funds to purchase financial products. It details specific financial products purchased, amounts, risk assessments, and risk control measures. The document is structured as a formal public announcement with no comprehensive financial statements or detailed financial performance analysis. It does not represent a full financial report such as an Annual Report (10-K) or Interim Report (IR). Instead, it is a regulatory announcement about financing activities related to investment in financial products. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about financing activities, not merely a brief notice or certification, so it is not RPA or RNS. Confidence is high given the clear content and context.
2020-03-10 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.